TCL Archive NCI Drug Development Program Produced 7 Drugs In 10 Years, Chabner Tells Group February 3, 1995
TCL Archive NCI To Fund About 4,100 Grants; Increase Planned In Average Costs; Paylines Stable November 20, 1998
TCL Archive FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says. January 14, 2005